Rituxanforgpampa-hcp - rituxanforgpampa-hcp.com : Inducing Remission in GPA & MPA Patients | Rituxan® GPA & MPA

1.67 Rating by ClearWebStats

rituxanforgpampa-hcp.com is 1 decade 4 months 3 weeks old. This website has a #22,232,200 rank in global traffic. It has a .com as an domain extension. This domain is estimated value of $ 8.95 and has a daily earning of $ 0.15. While no active threats were reported recently by users, rituxanforgpampa-hcp.com is SAFE to browse.

Updated 9 years 4 months ago

Get Custom Widget

Traffic Report of Rituxanforgpampa-hcp

Daily Unique Visitors:	22
Daily Pageviews:	44

Estimated Valuation

Income Per Day:	$ 0.15
Estimated Worth:	$ 8.95

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	Not Applicable

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	Not Applicable
Alexa BackLinks:	3

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	Not Applicable
WOT Trustworthiness:	Not Applicable
WOT Privacy:	Not Applicable
WOT Child Safety:	Not Applicable

Website Ranks & Scores

Google Pagerank:	Not Applicable
Alexa Rank:	22,232,200
Domain Authority:	Not Applicable

Google Pagerank

PR 0 out of 10

PageSpeed Score

Siteadvisor Rating

Not Applicable

Where is rituxanforgpampa-hcp.com server located?

Hosted IP Address:

72.34.128.84

View other site hosted with rituxanforgpampa-hcp.com

Hosted Country:

Location Latitude:

45.4207

Location Longitude:

-122.671

Social Engagement

Facebook Shares:	2
Facebook Likes:	Not Applicable
Facebook Comments:	Not Applicable
Twitter Count (Tweets):	Not Applicable
Linkedin Shares:	Not Applicable
Delicious Shares:	Not Applicable

Page Resources Breakdown

View rituxanforgpampa-hcp.com HTML resources

Homepage Links Analysis

View rituxanforgpampa-hcp.com homepage link analysis

Page Title of Rituxanforgpampa-hcp

Inducing Remission in GPA & MPA Patients | Rituxan® GPA & MPA | HCP

Meta Description of Rituxanforgpampa-hcp

Find information for healthcare professionals about Rituxan® (rituximab), the only FDA-approved treatment proven to induce remission in patients with GPA and MPA. INDICATION STATEMENT - Rituxan® (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Limitations of Use: Rituxan is not recommended for use in patients with severe, active infections BOXED WARNINGS and Additional Important Safety Information BOXED WARNINGS Infusion Reactions: Rituxan administration can result in serious, including fatal, infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion. Monitor patients closely. Discontinue Rituxan infusion for severe reactions and provide medical treatment for Grade 3 or 4 infusion reactions. Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. Hepatitis B Virus (HBV) Reactivation: HBV reactivation can occur in patients treated with Rituxan, in some cases resulting in fulminant hepatitis, hepatic failure, and death. Screen all patients for HBV infection before treatment initiation, and monitor patients during and after treatment with Rituxan. Discontinue Rituxan and concomitant medications in the event of HBV reactivation. Progressive Multifocal Leukoencephalopathy (PML): PML, including fatal PML, can occur in patients receiving Rituxan. Warnings and Precautions Rituxan administration can also result in additional serious, including fatal, adverse reactions including: - Tumor lysis syndrome (TLS): Administer aggressive intravenous hydration, anti‑hyperuricemic agents, monitor renal function - Infections: Withhold Rituxan and institute appropriate anti-infective therapy - Cardiac arrhythmias and angina: Discontinue infusions in case of serious or life-threatening events - Bowel obstruction and perforation: Consider and evaluate for abdominal pain, vomiting, or related symptoms - Live virus vaccines: Do not administer live virus vaccines prior to or during Rituxan - Cytopenias: Monitor blood counts at regular intervals Granulomatosis With Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Use of concomitant immunosuppressants other than corticosteroids has not been studied in GPA or MPA patients exhibiting peripheral B-cell depletion following treatment with Rituxan. Observe patients with GPA and MPA closely for signs of infection if immunosuppressants other than corticosteroids are used concomitantly - The safety and efficacy of retreatment with Rituxan have not been established in patients with GPA and MPA - Common adverse reactions (≥15%) in the clinical study were infections, nausea, diarrhea, headache, muscle spasms, anemia, and peripheral edema. Other important adverse reactions include infusion reactions You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. For additional safety information, please see the Rituxan full prescribing information, including BOXED WARNINGS.

Meta Tags of Rituxanforgpampa-hcp

rituxan, rituximab, rheumatoid arthritis treatment, ra treatment, ra medication, rheumatoid arthritis infusion treatment, rheumatoid arthritis symptoms, ra symptoms

Website Inpage Analysis

H1 Headings:	1	H2 Headings:	1
H3 Headings:	9	H4 Headings:	2
H5 Headings:	Not Applicable	H6 Headings:	Not Applicable
Total IFRAMEs:	Not Applicable	Total Images:	Not Applicable
Google Adsense:	Not Applicable	Google Analytics:	UA-48974804-1

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Sat, 29 Nov 2014 00:33:32 GMT
Content-Disposition: inline;filename="index.html"
Accept-Ranges: bytes
ETag: /_1416439454943
Last-Modified: Wed, 19 Nov 2014 23:24:14 GMT
Content-Range: bytes 0-42165/42165
Content-Length: 42165
Keep-Alive: timeout=1, max=100
Connection: close
Content-Type: text/html;charset=UTF-8
Content-Language: en

Domain Information for rituxanforgpampa-hcp.com

Domain Registrar:	CSC CORPORATE DOMAINS, INC.
Registration Date:	2013-11-27 1 decade 4 months 3 weeks ago
Last Modified:	2014-11-24 9 years 5 months 13 hours ago
Expiration Date:	2015-11-27 8 years 4 months 4 weeks ago

Domain Nameserver Information

Host		IP Address	Country
dnadns3e.gene.com		72.34.133.50	United States
dnadns4e.gene.com		72.34.128.50	United States

DNS Record Analysis

Host	Type	TTL	Extra
rituxanforgpampa-hcp.com	A	3594	IP:72.34.128.84
rituxanforgpampa-hcp.com	NS	3599	Target:dnadns2e.gene.com
rituxanforgpampa-hcp.com	NS	3599	Target:dnadns4e.gene.com
rituxanforgpampa-hcp.com	NS	3599	Target:dnadns3e.gene.com
rituxanforgpampa-hcp.com	SOA	3599	MNAME:bc-dns-ext-mstr.gene.com RNAME:postmaster.no.email.please Serial:414090283 Refresh:3600 Retry:600 Expire:2592000

Similarly Ranked Websites to Rituxanforgpampa-hcp

Home » Love Letters Photography

- lovelettersphoto.com

Hello & Welcome!!We are so happy to see you over in our little corner of the interwebs!!Love Letters Photography is a custom boutique photography studio offering natural light and limited indoor studio sessions. We specialize in maternity & newborn, family & children, and…